# Transdiagnostic Group Therapy (GBAT) for Autistic Adults With Personalized Therapeutics

> **NCT05512221** · NA · COMPLETED · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 33 (actual)

## Conditions studied

- GBAT+Individual
- GBAT+Engagement Booster
- GBAT+Both

## Interventions

- **OTHER:** GBAT+I, GBAT+E - Phase I
- **OTHER:** Watchful Waiting and Groups - Phase 2
- **OTHER:** GBAT+IE

## Key facts

- **NCT ID:** NCT05512221
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-23
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2024-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05512221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05512221, "Transdiagnostic Group Therapy (GBAT) for Autistic Adults With Personalized Therapeutics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05512221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*